DHPR α1S subunit controls skeletal muscle mass and morphogenesis

[1]  R. Kucherlapati,et al.  A Role for the CHC22 Clathrin Heavy-Chain Isoform in Human Glucose Metabolism , 2009, Science.

[2]  N. Norris,et al.  A dihydropyridine receptor alpha1s loop region critical for skeletal muscle contraction is intrinsically unstructured and binds to a SPRY domain of the type 1 ryanodine receptor. , 2009, The international journal of biochemistry & cell biology.

[3]  K. Beam,et al.  The Skeletal L-type Ca2+ Current Is a Major Contributor to Excitation-coupled Ca2+ entry , 2009, The Journal of general physiology.

[4]  V. Hill,et al.  Suppression of autophagy in skeletal muscle uncovers the accumulation of ubiquitinated proteins and their potential role in muscle damage in Pompe disease. , 2008, Human molecular genetics.

[5]  Parsa Safa,et al.  CaMKII locally encodes L-type channel activity to signal to nuclear CREB in excitation–transcription coupling , 2008, The Journal of cell biology.

[6]  I. Nonaka,et al.  Lysosomal myopathies: An excessive build-up in autophagosomes is too much to handle , 2008, Neuromuscular Disorders.

[7]  A. Laquérriere,et al.  Null mutations causing depletion of the type 1 ryanodine receptor (RYR1) are commonly associated with recessive structural congenital myopathies with cores , 2008, Human mutation.

[8]  H. Kern,et al.  Mechano-sensitivity of normal and long term denervated soleus muscle of the rat , 2008, Neurological research.

[9]  A. Goldberg,et al.  Coordinate activation of autophagy and the proteasome pathway by FoxO transcription factor , 2008, Autophagy.

[10]  A. Goldberg,et al.  FoxO3 controls autophagy in skeletal muscle in vivo. , 2007, Cell metabolism.

[11]  A. Goldberg,et al.  FoxO3 coordinately activates protein degradation by the autophagic/lysosomal and proteasomal pathways in atrophying muscle cells. , 2007, Cell metabolism.

[12]  D. Klionsky,et al.  Autophagosome formation: core machinery and adaptations , 2007, Nature Cell Biology.

[13]  Y. Itoyama,et al.  NO production results in suspension-induced muscle atrophy through dislocation of neuronal NOS. , 2007, The Journal of clinical investigation.

[14]  B. Rothen‐Rutishauser,et al.  Spinal muscular atrophy: SMN2 pre-mRNA splicing corrected by a U7 snRNA derivative carrying a splicing enhancer sequence. , 2007, Molecular therapy : the journal of the American Society of Gene Therapy.

[15]  P. Harvey,et al.  STRUCTURAL AND FUNCTIONAL CHARACTERIZATION OF INTERACTIONS BETWEEN THE DIHYDROPYRIDINE RECEPTOR II–III LOOP AND THE RYANODINE RECEPTOR , 2006, Clinical and experimental pharmacology & physiology.

[16]  Jiandie D. Lin,et al.  PGC-1α protects skeletal muscle from atrophy by suppressing FoxO3 action and atrophy-specific gene transcription , 2006, Proceedings of the National Academy of Sciences.

[17]  O. Danos,et al.  Long-term expression and repeated administration of AAV type 1, 2 and 5 vectors in skeletal muscle of immunocompetent adult mice , 2006, Gene Therapy.

[18]  G. Lanfranchi,et al.  Denervation in murine fast-twitch muscle: short-term physiological changes and temporal expression profiling. , 2006, Physiological genomics.

[19]  M. Falempin,et al.  Physiologically adaptive changes of the L5 afferent neurogram and of the rat soleus EMG activity during 14 days of hindlimb unloading and recovery , 2005, Journal of Experimental Biology.

[20]  S. Lecker,et al.  Ubiquitin-protein ligases in muscle wasting. , 2005, The international journal of biochemistry & cell biology.

[21]  A. Ferry,et al.  Effect of anti‐inflammatory and antioxidant drugs on the long‐term repair of severely injured mouse skeletal muscle , 2005, Experimental physiology.

[22]  C. Hourde,et al.  Functional, cellular and molecular aspects of skeletal muscle recovery after injury induced by snake venom from Notechis scutatus scutatus. , 2005, Toxicon : official journal of the International Society on Toxinology.

[23]  Luis Garcia,et al.  Rescue of Dystrophic Muscle Through U7 snRNA-Mediated Exon Skipping , 2004, Science.

[24]  H. Kern,et al.  Long‐Term Denervation in Humans Causes Degeneration of Both Contractile and Excitation‐Contraction Coupling Apparatus, Which Is Reversible by Functional Electrical Stimulation (FES): A Role for Myofiber Regeneration? , 2004, Journal of neuropathology and experimental neurology.

[25]  Marco Sandri,et al.  Foxo Transcription Factors Induce the Atrophy-Related Ubiquitin Ligase Atrogin-1 and Cause Skeletal Muscle Atrophy , 2004, Cell.

[26]  M. Matsui,et al.  In vivo analysis of autophagy in response to nutrient starvation using transgenic mice expressing a fluorescent autophagosome marker. , 2003, Molecular biology of the cell.

[27]  Vincent J Caiozzo,et al.  Skeletal muscle unweighting: spaceflight and ground-based models. , 2003, Journal of applied physiology.

[28]  Bruce M Carlson,et al.  Dynamics of postdenervation atrophy of young and old skeletal muscles: differential responses of fiber types and muscle types. , 2003, The journals of gerontology. Series A, Biological sciences and medical sciences.

[29]  S. Dooley,et al.  Smad7 prevents activation of hepatic stellate cells and liver fibrosis in rats. , 2003, Gastroenterology.

[30]  P. Thompson.  Introduction to Review series , 2002 .

[31]  C. Ahern,et al.  Functional analysis of a frame-shift mutant of the dihydropyridine receptor pore subunit (α1S) expressing two complementary protein fragments , 2001, BMC Physiology.

[32]  B. Carlson,et al.  Interrelations of myogenic response, progressive atrophy of muscle fibers, and cell death in denervated skeletal muscle , 2001, The Anatomical record.

[33]  R. Parton,et al.  Endocytosis in skeletal muscle fibers. , 1999, Experimental cell research.

[34]  M. Morgan,et al.  Passive stretch modulates denervation induced alterations in skeletal muscle myosin heavy chain mRNA levels , 1999, Pflügers Archiv.

[35]  S. Bodine,et al.  Changes in myosin mRNA and protein expression in denervated rat soleus and tibialis anterior. , 1996, European journal of biochemistry.

[36]  M. Palacín,et al.  Isolation and characterization of distinct domains of sarcolemma and T-tubules from rat skeletal muscle. , 1995, The Biochemical journal.

[37]  G. Butler-Browne,et al.  Plasticity of human satellite cells , 1993, Neuromuscular Disorders.

[38]  J. Guénet,et al.  The gene coding for the α1 subunit of the skeletal dihydropyridine receptor (Cchl1a3=mdg) maps to mouse Chromosome 1 and human 1q32 , 1993, Mammalian Genome.

[39]  N Chaudhari,et al.  A single nucleotide deletion in the skeletal muscle-specific calcium channel transcript of muscular dysgenesis (mdg) mice. , 1992, The Journal of biological chemistry.

[40]  B. Adams,et al.  Regions of the skeletal muscle dihydropyridine receptor critical for excitation–contraction coupling , 1990, Nature.

[41]  K. Campbell,et al.  Subcellular distribution of the 1,4-dihydropyridine receptor in rabbit skeletal muscle in situ: an immunofluorescence and immunocolloidal gold- labeling study , 1989, The Journal of cell biology.

[42]  M. Lazdunski,et al.  Targets for calcium channel blockers in mammalian skeletal muscle and their respective functions in excitation-contraction coupling. , 1988, Biochemical and biophysical research communications.

[43]  K. Beam,et al.  Restoration of excitation—contraction coupling and slow calcium current in dysgenic muscle by dihydropyridine receptor complementary DNA , 1988, Nature.

[44]  M. Lazdunski,et al.  Restoration of dysgenic muscle contraction and calcium channel function by co-culture with normal spinal cord neurons , 1987, Nature.

[45]  A. Mallart,et al.  An electrophysiological study of skeletal muscle fibres in the ‘muscular dysgenesis’ mutation of the mouse , 1987, Pflügers Archiv.

[46]  G. Butler-Browne,et al.  Neonatal and adult myosin heavy chain isoforms in a nerve-muscle culture system , 1986, The Journal of cell biology.

[47]  B. Banker.  MUSCULAR DYSGENESIS IN THE MOUSE (mdg/mdg) I. ULTRASTRUCTURAL STUDY OF SKELETAL AND CARDIAC MUSCLE , 1977, Journal of neuropathology and experimental neurology.

[48]  S. Gluecksohn-waelsch,et al.  Fine structure of mutant (muscular dysgenesis) embryonic mouse muscle. , 1972, Developmental biology.

[49]  A. C. Pai,et al.  DEVELOPMENTAL GENETICS OF A LETHAL MUTATION, MUSCULAR DYSGENESIS (MDG), IN THE MOUSE. II. DEVELOPMENTAL ANALYSIS. , 1965, Developmental biology.

[50]  A. C. Pai,et al.  DEVELOPMENTAL GENETICS OF A LETHAL MUTATION, MUSCULAR DYSGENESIS (MDG), IN THE MOUSE. I. GENETIC ANALYSIS AND GROSS MORPHOLOGY. , 1965, Developmental biology.

[51]  A. Kelekar.  Introduction to the review series Autophagy in Higher Eukaryotes--a matter of survival or death. , 2008, Autophagy.

[52]  N. Mizushima,et al.  Autophagosomes in GFP-LC3 Transgenic Mice. , 2008, Methods in molecular biology.

[53]  Chun Cheng,et al.  Involvement of CAPON and Nitric Oxide Synthases in Rat Muscle Regeneration After Peripheral Nerve Injury , 2007, Journal of Molecular Neuroscience.

[54]  Takayoshi Kobayashi,et al.  Triad proteins and intracellular Ca2+ transients during development of human skeletal muscle cells in aneural and innervated cultures , 2004, Journal of Muscle Research & Cell Motility.